Related Experiment Video
Updated: Apr 9, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
925
Immunotherapy in acute myeloid leukemia
Dolores A Grosso1, Rosemary C Hess1, Mark A Weiss1
1Department of Medical Oncology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Cancer
|June 23, 2015
Summary
Immunotherapy shows promise for treating acute myeloid leukemia (AML) when chemotherapy has stalled. Research explores harnessing the immune system to fight AML, offering a less toxic alternative to stem cell transplants.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Cytotoxic chemotherapy for acute myeloid leukemia (AML) has seen limited progress over four decades.
- Immunotherapy, particularly the graft-versus-leukemia effect in allogeneic hematopoietic stem cell transplantation (HSCT), indicates the immune system's role in combating AML.
Purpose of the Study:
- To explore novel immunologic treatment approaches for AML.
- To investigate non-transplant-based immune strategies for AML treatment.
- To evaluate methods for stimulating endogenous immune responses or targeting AML antigens.
Main Methods:
- Review of existing evidence on immunotherapy in AML.
- Exploration of non-transplant-based immune strategies.
- Analysis of allogeneic HSCT mechanisms.
Main Results:
- Non-transplant immunotherapies aim to boost or restore the body's immune response against AML.
- These strategies offer lower toxicity compared to allogeneic HSCT.
- Current non-transplant approaches generally show inferior efficacy to HSCT.
Conclusions:
- Immunotherapy is a viable and attractive treatment modality for AML.
- Exploiting the immune system's potential is crucial for advancing AML treatment.
- Further research into immunotherapy is warranted given the limitations of current chemotherapy.
Related Concept Videos
01:27Tumor Immunotherapy
2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
02:50Combination Therapies and Personalized Medicine
6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K